HCM Marketplace

Medicare Part D benefits will include wider drug access, improved compliance and increased utilization, based upon the best-case pricing scenario for US Pharma companies.

The global pharmaceutical pricing and reimbursement environment is notoriously complex and continuously changing. Pharma companies must implement strategic pricing assessments across global markets and product lifecycle phases in order to develop effective pricing policies. By incorporating such assessments into portfolio evaluations and lifecycle planning, companies can enhance their understanding of potential price profiles for individual drugs and optimize future returns.

Business Insights’ report: Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies examines the tactical importance of price optimization throughout the product lifecycle. The key issues affecting pricing and reimbursement disciplines are identified and the market environments of individual countries are assessed. This report will also detail the global and lifecycle pricing strategies of new and established drugs, including actionable recommendations and detailed case studies, and provide forecasts for future pricing scenarios in major markets.
Develop effective pricing strategies based upon this report’s unique market forecasts for future pricing scenarios in key markets and understand the major issues affecting the global pricing landscape.

Key reasons to read this report

• Anticipate shifts in the global pricing environment with this report’s unique forecasts of the best-case, worst case and most likely pricing scenarios for major countries.
• Improve your price optimization strategies by assessing the impacts of pharmacoeconomic evaluations, parallel trade and re-importation, and generic substitution across key countries.
• Coordinate your reimbursement policies more effectively across global markets by evaluating the latest pricing developments in the markets of Japan, France, Germany, Italy, Spain, Canada, Australia, China, the US and the UK.
• Develop optimal global pricing strategies throughout the lifecycles of your leading drugs by examining key considerations during the phases of launch, patent protection and patent expiry.
• Benchmark the pricing tactics of leading companies with this report’s range of successful case studies for a variety of drugs and pricing environments.

The report will be delivered as a PDF via e-mail. Orders must be paid in full before shipment. All sales are final; no returns or refunds are permitted with this product. For more information, please call 877/437-4276 or e-mail epharm@hcpro.com

• Reports

• Other Marketing Products